Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.
äŒæ¥ã³ãŒãEMBC
äŒç€ŸåEmbecta Corp
äžå Žæ¥Mar 21, 2022
æé«çµå¶è²¬ä»»è
ãCEOãKurdikar (Devdatt)
åŸæ¥å¡æ°1850
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Mar 21
æ¬ç€Ÿæåšå°300 Kimball Drive
éœåžPARSIPPANY
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·07054
é»è©±çªå·18624010000
ãŠã§ããµã€ãhttps://www.embecta.com/
äŒæ¥ã³ãŒãEMBC
äžå Žæ¥Mar 21, 2022
æé«çµå¶è²¬ä»»è
ãCEOãKurdikar (Devdatt)